CoChat

Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Sarcopenia has been recognized as a muscle disease, with adverse consequences on health. Updated recommendations, aimed at increasing awareness of sarcopenia and its accompanying risks, have been produced to urge the early detection and treatment of this disease. Recommended treatment is based on an individually tailored resistance exercise training program, the optimization of protein intake using high-quality protein sources (i.e., whey protein) in order to provide a high amount of essential amino acids—particularly leucine—and addressing vitamin D deficiency/insufficiency. The purpose of this review is to collate and describe all of the relevant efficacy studies carried out with a muscle-targeted oral nutritional supplementation (MT-ONS)—namely a whey-protein-based, leucine- and vitamin D-enriched formula aimed at optimizing their intake and satisfying their requirements—in different patient populations and clinical settings in order to determine if there is enough evidence to recommend prescription for the treatment of sarcopenia or its prevention in high-risk patient populations. Trials using a MT-ONS with or without a concomitant physical exercise program were systematically searched (up to June 2021), and those addressing relevant endpoints (muscle mass, physical performance and function) were critically reviewed. In total, 10 articles providing efficacy data from eight trials were identified and narratively reviewed. As far as older patients with sarcopenia are concerned, MT-ONS has been pertinently tested in six clinical trials (duration 4–52 weeks), mostly using a high-quality randomized controlled trial design and demonstrating efficacy in increasing the muscle mass and strength, as well as the physical performance versus iso-caloric placebo or standard practice. Consistent results have been observed in various clinical settings (community, rehabilitation centers, care homes), with or without adjunctive physical exercise programs. A positive effect on markers of inflammation has also been shown. A muscle-protein-sparing effect, with benefits on physical performance and function, has also been demonstrated in patients at risk of losing skeletal muscle mass (three trials), such as older patients undergoing weight loss or intensive rehabilitation programs associated with neurological disability (Parkinson’s disease). MT-ONS has demonstrated not only a significant efficacy in clinical variables, but also a positive impact on healthcare resource consumption in the rehabilitation setting (length of stay and duration of rehabilitation). In summary, MT-ONS, alone or in association with an appropriate exercise program, is an effective therapy for older patients with sarcopenia and should be offered as a first-line treatment, not only to improve clinical outcomes but also to reduce healthcare resource consumption, particularly in patients admitted to a rehabilitation center.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu14071524

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Serum levels (in healthy older subjects) of: (A) leucine (Leu) and essential amino acids (EAA) in response to the ingestion of a low-calorie (150 kcal) casein-based and leucine-enriched whey-protein-based (muscle-targeted) ONS; (B) insulin in response to the ingestion of a low-calorie (150 kcal) and a high-calorie (300 kcal) muscle-targeted ONS (MT-ONS). Adapted from the study by Luiking et al. [39].
Figure 1 Serum levels (in healthy older subjects) of: (A) leucine (Leu) and essential amino acids (EAA) in response to the ingestion of a low-calorie (150 kcal) casein-based and leucine-enriched whey-protein-based (muscle-targeted) ONS; (B) insulin in response to the ingestion of a low-calorie (150 kcal) and a high-calorie (300 kcal) muscle-targeted ONS (MT-ONS). Adapted from the study by Luiking et al. [39].CC BY · PubMed Central
Figure 2 The effect of muscle-targeted ONS (whey protein, leucine and vitamin D) in combination with exercise in increasing appendicular muscle mass in older adults with sarcopenia (the present figure is used with permission from Danone Nutricia Research BV for this single publication).
Figure 2 The effect of muscle-targeted ONS (whey protein, leucine and vitamin D) in combination with exercise in increasing appendicular muscle mass in older adults with sarcopenia (the present figure is used with permission from Danone Nutricia Research BV for this single publication).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 139

Metadata

Authors
Cereda, E., Pisati, R., Rondanelli, M., & Caccialanza, R.
Affiliations
  • Policlinico San Matteo Fondazione (IT)
  • University of Pavia (IT)
Corresponding author
Cereda, Emanuele
Venue
Nutrients
Publisher
MDPI AG
Published
2022-04-06
Volume
14
Issue
7
Pages
1524
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4223616061
Cited by
139
References
65
Citations by year
2026: 29 · 2025: 48 · 2024: 30 · 2023: 28 · 2022: 4
FWCI
3.78
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
Keywords
sarcopenia, whey protein, oral nutritional supplementation, leucine, vitamin D, muscle mass, muscle strength, physical performance, older adults, Parkinson's disease, rehabilitation, weight loss, inflammatory markers, health care utilization, resistance training, sarcopenia prevention, care homes, nursing homes, community-dwelling older adults
MeSH terms
Whey Proteins, Humans, Leucine, Vitamins, Randomized Controlled Trials as Topic, Muscle, Skeletal, Dietary Supplements, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia. https://app.cochat.ai/papers/10.3390/nu14071524
The paper
Cereda, E., Pisati, R., Rondanelli, M., & Caccialanza, R. (2022). Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia. Nutrients. https://doi.org/10.3390/nu14071524

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.